Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001967247 | SCV002205612 | uncertain significance | MHC class II deficiency | 2021-10-16 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This variant has not been reported in the literature in individuals affected with RFX5-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change affects codon 181 of the RFX5 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the RFX5 protein. |